ArticleInternational journal of molecular medicine2019

miR‑505 inhibits cell growth and EMT by targeting MAP3K3 through the AKT‑NFκB pathway in NSCLC cells.

Huaping Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.